Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 449

    1.

    Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillation.

    Boulanger L, Hauch O, Friedman M, Foster T, Dixon D, Wygant G, Menzin J.

    Ann Pharmacother. 2006 Jun;40(6):1024-9. Epub 2006 May 30.PMID: 16735649 [PubMed - indexed for MEDLINE]Related articles

    2.

    Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

    Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, Jensvold NG, Selby JV, Singer DE.

    JAMA. 2003 Nov 26;290(20):2685-92.PMID: 14645310 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.

    Gulløv AL, Koefoed BG, Petersen P.

    Arch Intern Med. 1999 Jun 28;159(12):1322-8.PMID: 10386508 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Predictors of warfarin use among Ohio medicaid patients with new-onset nonvalvular atrial fibrillation.

    Johnston JA, Cluxton RJ Jr, Heaton PC, Guo JJ, Moomaw CJ, Eckman MH.

    Arch Intern Med. 2003 Jul 28;163(14):1705-10.PMID: 12885686 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Prevention of stroke in patients with atrial fibrillation.

    Olsson SB, Halperin JL.

    Semin Vasc Med. 2005 Aug;5(3):285-92. Review.PMID: 16123916 [PubMed - indexed for MEDLINE]Related articles

    6.

    The impact of pharmacist-managed oral anticoagulation therapy in older veterans.

    Poon IO, Lal L, Brown EN, Braun UK.

    J Clin Pharm Ther. 2007 Feb;32(1):21-9.PMID: 17286786 [PubMed - indexed for MEDLINE]Related articles

    8.

    Use of warfarin for nonvalvular atrial fibrillation in nursing home patients.

    Lackner TE, Battis GN.

    Arch Fam Med. 1995 Dec;4(12):1017-26.PMID: 7496550 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.

    Willey VJ, Bullano MF, Hauch O, Reynolds M, Wygant G, Hoffman L, Mayzell G, Spyropoulos AC.

    Clin Ther. 2004 Jul;26(7):1149-59.PMID: 15336480 [PubMed - indexed for MEDLINE]Related articles

    11.

    Anticoagulation therapy in patients with chronic atrial fibrillation: a retrospective claims data analysis.

    Harley CR, Riedel AA, Hauch O, Nelson M, Wygant G, Reynolds M.

    Curr Med Res Opin. 2005 Feb;21(2):215-22.PMID: 15801992 [PubMed - indexed for MEDLINE]Related articles

    12.

    Gains and losses of warfarin therapy as performed in an anticoagulation clinic.

    Njaastad AM, Abildgaard U, Lassen JF.

    J Intern Med. 2006 Mar;259(3):296-304.PMID: 16476107 [PubMed - indexed for MEDLINE]Related articles

    13.

    Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients.

    Shireman TI, Howard PA, Kresowik TF, Ellerbeck EF.

    Stroke. 2004 Oct;35(10):2362-7. Epub 2004 Aug 26.PMID: 15331796 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.

    Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE.

    Ann Intern Med. 1999 Dec 21;131(12):927-34.PMID: 10610643 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis.

    Choudhry NK, Anderson GM, Laupacis A, Ross-Degnan D, Normand SL, Soumerai SB.

    BMJ. 2006 Jan 21;332(7534):141-5. Epub 2006 Jan 10.PMID: 16403771 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The impact of warfarin use on clinical outcomes in atrial fibrillation: a population-based study.

    Parkash R, Wee V, Gardner MJ, Cox JL, Thompson K, Brownell B, Anderson DR.

    Can J Cardiol. 2007 May 1;23(6):457-61.PMID: 17487290 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic.

    Abdelhafiz AH, Wheeldon NM.

    Clin Ther. 2004 Sep;26(9):1470-8.PMID: 15531009 [PubMed - indexed for MEDLINE]Related articles

    18.

    Development of a contemporary bleeding risk model for elderly warfarin recipients.

    Shireman TI, Mahnken JD, Howard PA, Kresowik TF, Hou Q, Ellerbeck EF.

    Chest. 2006 Nov;130(5):1390-6.PMID: 17099015 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Use of resources and cost implications of stroke prophylaxis with warfarin for patients with nonvalvular atrial fibrillation.

    Abdelhafiz AH, Wheeldon NM.

    Am J Geriatr Pharmacother. 2003 Dec;1(2):53-60.PMID: 15555467 [PubMed - indexed for MEDLINE]Related articles

    20.

    Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

    DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M; AFFIRM Investigators.

    Am Heart J. 2005 Apr;149(4):650-6.PMID: 15990748 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data